ConSynance Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for rare central nervous system diseases. Their focus lies in addressing hypothalamic dysregulation-related conditions, such as Prader-Willi Syndrome, hypothalamic injury-induced obesity, and other neurological disorders.
With a mission to transform breakthrough science into transformative treatments, ConSynance Therapeutics aims to provide hope and relief to patients suffering from these challenging conditions.
Generated from the website